Marquette Asset Management’s Boston Scientific BSX Stock Holding History

Marquette Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.5K	Buy	387 +323	+505%	+$17.5K	﹤0.01%	257
2026 Q1	$4.02K	Buy	+64	New	+$5.12K	﹤0.01%	392
2025 Q4	–	Sell	-204	Closed	-$19.9K	–	729
2025 Q3	$19.9K	Buy	+204	New	+$21.1K	﹤0.01%	146
2022 Q3	–	Sell	-11	Closed	–	–	251
2022 Q2	$0	Hold	11	–	–	﹤0.01%	304
2022 Q1	$0	Buy	+11	New	+$477	﹤0.01%	356

Other funds holding BSX

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Marquette Asset Management's BSX Position: Q2 2026 in Review

Marquette Asset Management increased its Boston Scientific (BSX) stake by 505% in Q2 2026, buying an estimated $17.5K and bringing the position to 387 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

Marquette Asset Management first reported a position in BSX in Q1 2022 and has held it in 5 quarters since. The position peaked at $19.9K in Q3 2025. 713 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Marquette Asset Management held 387 shares of Boston Scientific worth $16.5K as of Q2 2026.
Marquette Asset Management bought 323 Boston Scientific shares in Q2 2026, an estimated $17.5K.
Boston Scientific made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #257 holding.
Marquette Asset Management first reported a position in Boston Scientific in Q1 2022 and has held it in 5 quarters since.
Marquette Asset Management's Boston Scientific position peaked at $19.9K in Q3 2025.
713 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.